Literature DB >> 9500320

Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

A J Wakefield1, S H Murch, A Anthony, J Linnell, D M Casson, M Malik, M Berelowitz, A P Dhillon, M A Thomson, P Harvey, A Valentine, S E Davies, J A Walker-Smith.   

Abstract

BACKGROUND: We investigated a consecutive series of children with chronic enterocolitis and regressive developmental disorder.
METHODS: 12 children (mean age 6 years [range 3-10], 11 boys) were referred to a paediatric gastroenterology unit with a history of normal development followed by loss of acquired skills, including language, together with diarrhoea and abdominal pain. Children underwent gastroenterological, neurological, and developmental assessment and review of developmental records. Ileocolonoscopy and biopsy sampling, magnetic-resonance imaging (MRI), electroencephalography (EEG), and lumbar puncture were done under sedation. Barium follow-through radiography was done where possible. Biochemical, haematological, and immunological profiles were examined.
FINDINGS: Onset of behavioural symptoms was associated, by the parents, with measles, mumps, and rubella vaccination in eight of the 12 children, with measles infection in one child, and otitis media in another. All 12 children had intestinal abnormalities, ranging from lymphoid nodular hyperplasia to aphthoid ulceration. Histology showed patchy chronic inflammation in the colon in 11 children and reactive ileal lymphoid hyperplasia in seven, but no granulomas. Behavioural disorders included autism (nine), disintegrative psychosis (one), and possible postviral or vaccinal encephalitis (two). There were no focal neurological abnormalities and MRI and EEG tests were normal. Abnormal laboratory results were significantly raised urinary methylmalonic acid compared with age-matched controls (p=0.003), low haemoglobin in four children, and a low serum IgA in four children.
INTERPRETATION: We identified associated gastrointestinal disease and developmental regression in a group of previously normal children, which was generally associated in time with possible environmental triggers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9500320     DOI: 10.1016/s0140-6736(97)11096-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  376 in total

1.  Vaccination policies: individual rights v community health. We can't afford to be half hearted about vaccination programmes.

Authors:  S King
Journal:  BMJ       Date:  1999-12-04

2.  MMR vaccine: the continuing saga.

Authors:  D Elliman; H Bedford
Journal:  BMJ       Date:  2001-01-27

Review 3.  Concerns about immunisation.

Authors:  H Bedford; D Elliman
Journal:  BMJ       Date:  2000-01-22

4.  Is the MMR vaccine safe?

Authors:  C Edwards
Journal:  West J Med       Date:  2001-03

5.  Immunological treatments for autism.

Authors:  S Gupta
Journal:  J Autism Dev Disord       Date:  2000-10

6.  MMR immunisation. True anaphylaxis to MMR vaccine is extremely rare.

Authors:  J R Carapetis; N Curtis; J Royle
Journal:  BMJ       Date:  2001-10-13

7.  Measles, mumps, and rubella (MMR) vaccine and autism. Ecological studies cannot answer main question.

Authors:  L Smeeth; A J Hall; L C Rodrigues; X Huang; P G Smith; E Fombonne
Journal:  BMJ       Date:  2001-07-21

8.  New evidence for a viral pathogenic mechanism for new variant inflammatory bowel disease and development disorder?

Authors:  A Morris; D Aldulaimi
Journal:  Mol Pathol       Date:  2002-04

9.  The discomfort of patient power.

Authors:  Richard Smith
Journal:  BMJ       Date:  2002-03-02

10.  MMR vaccine debate. Debate crystallises dilemma facing many medical disciplines.

Authors:  Richard Fry
Journal:  BMJ       Date:  2002-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.